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Aims: This study was undertaken to identify the parameters of metabolic syndrome which can predict
cardiovascular and peripheral vascular disease.
Subject: A total of 260 subjects were selected from Ibrahim Cardiac Hospital and Research Institute
(ICHRI), who reported for coronary angiogram as per advice of a cardiologist.
Method: Each subject undergoing angiogram was interviewed with a preset structured questionnaire.
The study subjects were screened for PVD (peripheral vascular disease) by examining peripheral pulses
and ankle brachial index measured. Subjects with absent pulse or non-recordable ankle brachial index
was considered as ankle brachial index <0.9. Positive angiographic ﬁnding was deﬁned by presence of
mild to severe degree of coronary vascular narrowing of one or multiple of three coronary arteries.
Result: Among the study subjects 64.6% had metabolic syndrome, 79.2% had positive and 20.8% had
normal angiographic ﬁnding. Among the CAG positive subjects 38.8% had single vessel disease, 30.0%
had double vessel disease and 31.08% had triple vessel disease. CAG positive subjects are mostly 40–
60 years of age, 78.6% male, 54.8% smoker, 62.1% had waist circumference above normal, and about
90% have dyslipidemia and dysglycemia (DM/IGT/IFG). In this study subjects 83.9% of diabetic and
69.7% of non-diabetic had positive angiographic ﬁnding. Among the CAG positive subjects 16.6% had
low ABI (<0.9).
Conclusions: This study reveals that hypertriglyceridemia, waist circumference and hypertension are sig-
niﬁcantly related with angiographic positivity. Peripheral vascular disease was not signiﬁcantly higher
among CAG positive subjects and no association was observed between metabolic syndrome and PVD.
 2010 International Journal of Diabetes Mellitus. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license.1. Introduction
Metabolic syndrome is a clustering of metabolic abnormalities
that has been associated with a risk of coronary heart disease,
stroke and cardiovascular mortality greater than that of its individ-
ual component. The prevalence of metabolic syndrome has varied
markedly between different studies, most likely because of the lack
of accepted criteria for the deﬁnition of the syndrome [1]. The
International Diabetes Federation (IDF) published new criteria for
identifying subjects with metabolic syndrome in 2005 [2]. Using
the IDF deﬁnition, the age-adjusted prevalence of MetS was
43.4% and included the majority of subjects older than 50 years.
In IDF MetS, the prevalence of abdominal obesity and high fasting
plasma glucose levels was much higher compared with the NCEP
ATP III deﬁnition [3].ellitus. Published by Elsevier Ltd.
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O1.1. Metabolic syndrome and cardiovascular risk
Each of the metabolic syndrome criteria is related to an in-
creased risk of developing cardiovascular disease. NHANES III
showed that approximately 24% of adult American had three or
more of ﬁve metabolic syndrome criteria [4]. Metabolically, several
risk factors tend to cluster in middle aged adults including HDL,
BMI, systolic blood pressure, triglyceride, cholesterol and blood
glucose. Some risk factors are related to the greater risk of CHD.
The presence of three or more metabolic risk factors leads to a dou-
bling of risk for CHD in men and a ﬁvefold increase in risk factor for
women [5]. The Framingham Study [6] shows that the components
of the syndrome that contributed most to cardiovascular disease
outcome were high blood pressure (33%) and low HDL cholesterol
(25%). The higher the number of abnormalities in an individual and
the more severe the magnitude of each abnormality, the more
likely the individual is to be insulin resistant/hyperinsulinemic.
The prevalence of metabolic syndrome depends on age, ethnic
background and gender [7]. It increases linearly from 20 to
50 years of age, and plateaus thereafter, with middle agedpen access under CC BY-NC-ND license.
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men the lowest. The role of the parental history of DM and HTN in
the occurrence of metabolic syndrome was studied in the risk of
atherosclerosis in communities’ study [7]. Metabolic syndrome
(MetS) is associated with an increased risk of cardiovascular dis-
ease events in the general populations [8]. The Hisayama Study,
a prospective cohort study of a general Japanese population with
a long duration of follow up, reported the association of metabolic
syndrome with the incidence of cardiovascular disease, using a
modiﬁed NCEP deﬁnition [9]. It also revealed that the risk of car-
diovascular disease increased in an incremental fashion, with the
number of components of metabolic syndrome, and becomes pre-
dictive of cardiovascular disease when the number of components
reached to three.
The objective of the study was to observe different parameters
of metabolic syndrome among people undergoing coronary angio-
gram, and to measure the impact of different component combina-
tions of the metabolic syndrome on cardiovascular disease, as well
as peripheral vascular disease.1.2. Metabolic syndrome and peripheral vascular disease
Peripheral vascular disease (PVD) is a manifestation of sys-
temic atherosclerosis, in which the arterial lumen of the lower
extremities becomes progressively occluded by atherosclerotic
plaque [10]. The prevalence of a peripheral vascular disease is
elevated in subjects with metabolic syndrome [11]. The assess-
ment of peripheral pulses and measurement of ankle brachial
index are tools for assessing peripheral vascular disease. The
ankle brachial index (ABI), i.e. the ratio of the ankle to brachial
systolic blood pressure, is the gold standard for the diagnosis
of peripheral arterial disease, and is a highly speciﬁc method
for the assessment of vascular risk in otherwise asymptomatic
patients. An ABI 6 0.90 is diagnostic of PAD. The measurement
of ABI by palpation in the setting of primary care, in patients
at intermediate cardiovascular risk, is a sufﬁciently sensitive
method to consider its use as a screening test for the exclusion
of PAD [12].Odds ratio :
Exposure to the risk factor among the disease group  non-exposure to the risk factor among the disease free group
Exposure to the risk factor among the disease free group  non-exposure to the risk factor among the disease group2. Patients and methods
The study was conducted in Ibrahim Cardiac Hospital and Re-
search Institute (ICHRI) during the period July 2008–March 2009.
It was an observational study. Subjects of 30–80 years age under-
going coronary angiogram in ICHRI who reported coronary angio-
gram (CAG) for the ﬁrst time, having either a cardiac event in the
past or enough clinical or investigational evidence (ECG, Echo,
ETT) of coronary artery disease were included in this study. Sub-
jects aging >80 years, or with associated co morbid disease (as
CKD, CLD or any acute illness), were excluded from the study.
Study subjects were chosen by purposive convenient sampling.
Two hundred and sixty subjects undergoing coronary angiogram,
as per the advice of a cardiologist, were interviewed through a pre-
set structured questionnaire, and examined on the morning of the
angiogram. Each subject undergoing angiogram completed a ques-
tionnaire covering medical history, family history of cardiovascular
disease, exercise, treatment for hypertension or diabetes, smoking
habits and alcohol intake. Fasting blood sugar was determined by aglucometer (the most accurate and popular meter supplied by Ab-
bott Company, named Optium Omega Glucometer) on the day of
CAG as routine test; the angiogram report was collected on the
subsequent day. Angiogram ﬁndings were scored by the same phy-
sician. The scoring system was deﬁned as mild (40–50% block);
moderate (50–70% block); or severe (>70% block).
Patients were briefed about the study and written consent
obtained.
Anthropometric Measurement was taken as follows: standing
height was measured using appropriate scales with minimal
clothes. Height was recorded in centimeters, to the nearest
5 mm. The balance was placed on a hard ﬂat surface, and checked
for zero balance before measurement. Weight was recorded to the
nearest 0.5 kg. Body mass index (BMI) of the subjects was calcu-
lated using a standard formula: BMI = Weight (kg)/(height in me-
ter)2. Waist circumference was measured to the nearest 0.5 cm,
with a soft non-elastic measuring tape. Blood pressure was mea-
sured using a standard sphygmomanometer in the supine position,
after a rest of at least 5 min. Among the laboratory reports, dysgly-
cemia was considered with fasting blood glucose P5.6 mmol/l, or
previously diagnosed or treated as IGT/IFG/DM, and dyslipidemia
was considered if S. Cholesterol > 200 mg/dl/TG > 150 mg/dl/
HDL < 40 mg/dl/LDL > 100 mg/dl and/or the patient was using lipid
lowering agents. ECG, ETT, Echocardiography and Lipid proﬁle data
were collected from the patient’s previous record (recent reports
done before angiogram). A Hewlett Packard conventional machine
was used for ECG. Conventional coronary angiography was done to
all subjects. In this study, metabolic syndrome is deﬁned by using
the criteria recommended by IDF.
Statistical analysis was performed using SPSS (Statistical Pack-
age for Social Sciences) version 16. All data were expressed as a
mean and standard deviation (SD). The standard error of mean
(SE), range, percentage and 95% Conﬁdence Interval (CI) for a con-
tinuous variable. Chi square test (v2) was used for the comparison
of qualitative data, and the comparison between groups was done
by t-test. Results were considered statistically. Data was consid-
ered signiﬁcant at P-value <0.05. The Odds Ratio was calculated
by the following formula:Multiple regression analysis was done to see the effect of different
risk factors on clinical outcome.3. Results
3.1. Clinical and biochemical characteristics of study subjects
Seventy ﬁve (28.84%) subjects were female, and 185 (71.15%)
were male. The age (years) as mean ± SD was 53.58 (±9.70). Smok-
ing habit and alcohol ingestion were present in 59 (22.69%) and 7
(2.69%) subjects. One hundred and ﬁfteen (44.23%) subjects had a
family history of cardiovascular disease. BMI (kg/m2) was 24.84
(±3.22). FPG (mmol/l) (mean ± SD) was 7.92 (±2.72). The mean
(±SD) of waist circumference was 91.71 (±7.97). TG (mean ± SD),
cholesterol (mean ± SD), LDL (mean ± SD), HDL (mean ± SD) were
123.94 (±11.67), 190.89 (±46.09), 117.69 (±73.35) and 37.02
(±9.08). The mean ± SD of systolic blood pressure (mmHg) and
F. Afsana et al. / International Journal of Diabetes Mellitus 2 (2010) 83–87 85diastolic blood pressure (mmHg) was 123.94 (±11.67) and 78.71
(±5.06).
3.2. Angiographic characteristics of study subjects
Among the study subjects 20.8% (n = 54) had normal and 79.2%
(206) had positive angiographic ﬁnding (Table 1). Among the posi-
tive cases, 30.8% (n = 80) had single vessel disease, 23.8% (n = 62)
had double vessel disease, and 24.6% (n = 64) had triple vessel
disease.
3.3. Characteristics of different parameters of metabolic syndrome
Among the subjects having normal angiographic ﬁnding
(Table 2) 75.92% had a waist circumference above normal
(>80 cm for female and >90 cm for female), 88.88% had hypertri-
glyceridemia, 87.03% had raised fasting glucose (or any form of
dysglycemia), 85.18% had raised systolic pressure, 74.07% had
raised diastolic pressure and 12% had low HDL. Subjects having po-
sitive angiographic ﬁndings had the following distribution of dif-
ferent parameters of metabolic syndrome: 62.13% had a waist
circumference above normal, 96.11% had hypertriglyceridemia,
90.29% had raised fasting glucose (or any form of dysglycemia),
85.1% had raised systolic pressure, 75.72% had raised diastolic
pressure and 21.97% had low HDL. Normal and positive angio-
graphic groups had a statistically signiﬁcant difference in waist cir-
cumference, S. triglyceride level and systolic blood pressure
(P = 0.040, 0.047, 0.007, respectively). Considering the different
angiographic ﬁnding (single vessel/double vessel/triple vessel)
there is a signiﬁcant difference in waist circumference, and S. tri-
glyceride level (P = 0.041, 0.022, respectively) in these three vari-
ants (Table 2).
3.4. Clinical and biochemical characteristics of subjects with different
angiographic ﬁndings
The total number of study subjects undergoing coronary angio-
gram was 260. Of these, 79.23% (n = 206) were angiogram positive
(Table 2). Among the subjects undergoing coronary angiogram
87.5% (n = 162) male and 58.6% (n = 44) female had positive angio-Table 1
Distribution of angiographic ﬁndings among study subjects.
Frequency Percent
Normal 54 20.8
Abnormal
Single vessel 80 30.7
Double vessel 62 23.8
Triple vessel 64 24.6
Total 260 100.0
Table 2
Characteristics of different parameters of metabolic syndrome according to angiographic p
CAG status % WC above normal (%) Hyper TG (%)
Normal (n = 54) 20.8 75.9 88.8
Abnormal (n = 206) 79.2 62.1 96.1
P-value 0.040 0.047
Single vessel (n = 80) 30.8 68.7 95.0
Double vessel (n = 62) 23.8 51.6 96.7
Triple vessel (n = 64) 24.7 64.0 96.8
P-value 0.041 0.022
WC, waist circumference; Hyper TG, hypertriglyceridemia; dysglycemia, raised FPG or p
pressure; AntiHTN, antihypertensive drug.graphic ﬁndings. Positive angiographic ﬁndings were found in 56%
of subjects <40 years of age, 80.7% of 40–60 years and 87% of sub-
jects >60 years of age. About 81% (81.6%) of exercising subjects and
77.03% of no exercising subjects showed angiogram positivity.
Smokers were 88.13% angiogram positive and non-smokers
70.99%. Subjects with a positive family history of cardiac disease
were angiogram positive at 80.86%, in contrast to 77.93% with no
previous family history. Angiogram was positive in 83.3% of sub-
jects with normal BMI (<25 kg/m2) and 89.2%with higher BMI
(>25 kg/m2). Subjects with normal waist circumference were
85.71% angiogram positive, 75.73% of subjects with abnormal waist
circumference were angiogram positive. Among subjects with high
cholesterol, 80.93% were angiogram positive and 62.5% of subjects
with normal cholesterol were angiogram positive. High LDL and
normal LDL showed 78.9% and 82.6% of angiographic positivity,
respectively. Subjects with normal triglyceride were 57.14% angio-
gram positive, and hypertriglyceridemic subjects were 80.48%
angiogram positive. Among subjects, 76.34% with normal HDL
and 86.95% with low HDL were angiogram positive. Subjects with
low ankle brachial index were 55.67% angiography positive and
subjects with normal ankle brachial index were 93.2% angiography
positive. About 62.13% of subjects with metabolic syndrome
showed angiographic positivity. Angiographic positivity was found
in 81.14% of hypertensive (systolic) subjects, and 50% of normoten-
sive subjects. Subjects with diastolic hypertension were 79.59%
angiogram positive, in contrast to 78.12% with normal diastolic
blood pressure. Male sex, increased age, smoking, waist circumfer-
ence, raised S. Cholesterol and S. triglyceride and systolic hyperten-
sion were signiﬁcantly related to angiogram positivity (P = 0.000,
0.003, 0.004, 0.040, 0.037, 0.047, 0.007, respectively).3.5. Characteristics of angiogram positive subjects
Among angiogram positive subjects, 78.64% were male and
21.36% were female, 8.29% were <40 years, 68.7% were 40–60 years
and 22.92% were >60 years of age. Among them, 48.51% took exer-
cise, 54.85% were smokers, 45.15% had a positive family history of
CAD, 44.18% had a high BMI, 62.13% had a waist circumference
above normal, 16.6% had low ankle brachial index, 92.7% had
hypercholesterolemia, 96.11% had hypertriglyceridemia, 19.41%
had low HDL, 90.71% had high LDL, 90.29% had raised fasting blood
glucose, and 62.13% had metabolic syndrome.3.6. Distribution of metabolic syndrome and diabetes in study subjects
Of the total subjects in this study that underwent coronary
angiogram, 66.9% (n = 174) were diabetic and 33.1% were non-dia-
betic (Table 3). On the other hand, all the control subjects were dia-
betic. Among the total study subjects (n = 260), 64.6% (n = 168) had
metabolic syndrome and 35.4% had not (according to IDF criteria).ositivity.
Dysglycemia (%) Raised SBP or
on anti HTN (%)
Raised DBP or
on anti HTN (%)
Low HDL (%)
87.0 85.1 74.0 12
90.2 85.1 75.7 21.9
0.316 0.007 0.464 0.082
85.0 95.0 78.7 23.5
93.5 98.3 67.7 19.2
93.7 95.3 79.6 22.8
0.372 0.219 0.195 0.417
reviously diagnosed DM/IGT/IFG; SBP, systolic blood pressure; DBP, diastolic blood
Table 3
Metabolic syndrome and diabetes among study subjects.
Frequency Percentage
Metabolic syndrome
Present 168 64.6
Absent 92 35.4
Diabetes
Present 174 66.9
Absent 86 33.1
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Fig. 1. Presence of metabolic syndrome in different angiographic status.
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Of the study subjects, 68.39% (n = 119) of diabetic (subjects) and
58.13% (n = 86) of non-diabetic (subjects) had metabolic syndrome
(Table 4).
Table 4 shows that concerning the risk of developing diabetes,
among the people those who have metabolic syndrome has .90
times higher than those who do not have exposure among the risk
factor.
3.8. Relation of positive angiographic ﬁnding with different
components of metabolic syndrome
Multiple regression analysis of different parameters of
metabolic syndrome, with angiographic ﬁndings as the dependent
variable, reveals that waist circumference (P = 0.033), blood pres-
sure (0.007) and S. triglyceride (0.036) are positively correlated
with positive angiographic ﬁndings. S. HDL and FBG did not show
any positive inﬂuence on angiographic positivity.
Table 5 shows that the Odds Ratio is greater than one and the
P-value is signiﬁcant (less than 0.05). This means that these factors
lead to a high risk of developing MS among patients undergoing
angiography; otherwise there was less risk of developing it.
3.9. Presence of metabolic syndrome in different angiographic ﬁnding
Among the 260 subjects undergoing CAG, 168 had MetS. Among
them, 56 (33.33%) had single vessel disease, 31 (18.45%) hadTable 4
Diabetes and metabolic syndrome in study subjects.
MS Total P-value Odds ratio
Absent Present
Non-diabetic
Count 36 86 86
% of total 41.8 58.1 100
Diabetic
Count 55 119 174 0.073 0.90
% of total 31.6 68.3 100
Count 91 169 260
% of total 35 65 100
Table 5
Multiple regression analysis with angiographic ﬁnding as a dependent variable and
individual components of metabolic syndrome as independent variables in study
subjects.
CAG positive B P-value Odds ratio Conﬁdence interval
Lower bound Upper bound
Intercept 3.5 0.055
Waist 0.8 0.033 2.2 1.06 4.84
B.P 1.5 0.007 0.2 0.06 0.64
S.TG 1.3 0.036 0.2 0.07 0.91
S. HDL 0.7 0.113 0.4 0.17 1.20
FPG 0.1 0.845 1.1 0.36 3.37double vessel disease, 41 (24.40%) had triple vessel disease, and
40 (23.80%) had normal angiographic ﬁnding (Fig. 1).
3.10. PVD among study subjects
The study subjects were screened for PVD (peripheral vascular
disease). It revealed that 74.62% (n = 194) subjects had normal an-
kle brachial index and 25.3% (n = 66) had ankle brachial index <0.9.
Subjects with low ankle brachial index were 55.6% CAG positive
and subjects with normal ankle brachial index were 93.2% CAG po-
sitive. It states that presence of PVD (Evidenced by ABI <0.9) does
not affects angiographic positivity. On the other way among the
CAG positive subjects 16.6% had low ankle brachial index.
4. Discussion
Metabolic syndrome has been most widely promoted as a
means to identify patients for lifestyle intervention, so as to reduce
risk factor levels and, in theory, incident disease, particularly CVD.
The Framingham Risk Score is a widely available, extensively vali-
dated prediction rule for deﬁning the probability of a coronary
heart disease event in diverse population [1].
In this study, the prevalence of MetS is 64.6%. The age-adjusted
prevalence of metabolic syndrome (MetS) is some what different
between men and women. The prevalence of MetS was lower in
women than men in NHANES 1988–1994; whereas the prevalence
was higher in women in the later 1999–2002 cohort [13]. The rea-
son for the increase is likely to be due to changes in the racial and
ethnic composition of the female cohort. In this study, MetS is also
more prevalent among female subjects.
The IDF consensus group states that this new deﬁnition empha-
sizes the importance of central obesity, with modiﬁcations accord-
ing to ethnic group encouraging the clinical diagnosis of almost all
cases of metabolic syndrome. The deﬁnition thus identiﬁes the ac-
tual group of patients who are at increased risk of developing cor-
onary artery disease and/or type 2 diabetes. In consequence, IDF
deﬁnition, which has central obesity as its prerequisite, may be rel-
atively less restrictive than NCEP: ATP III. In this study, in consid-
ering the IDF present statement, the new IDF deﬁnition is used to
deﬁne metabolic syndrome.
While comparing the subgroups of subjects (normal vs. positive
angiographic group) undergoing coronary angiogram male sex,
aging and smoking signiﬁcantly inﬂuence the angiographic ﬁnd-
ings. Accordingly waist circumference, dyslipidemia (hypercholes-
terolemia and hypertriglyceridemia) and hypertension are more
prevalent in angiogram positive subjects, i.e. higher percentage of
angiogram positive subjects are having these three parameters of
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mary observations regarding the clustering of metabolic disorders
was the association of these features with increased cardiovascular
risk. It is well accepted and established that multiple risk factors
confer greater risk than a single risk factor. The more components
of MetS that are present, the greater the cardiovascular risk [13].
The Framingham experience has certainly suggested that multiple
risk factors increase the risk of CVD more than the sum of the indi-
vidual risk factors [13]. In different studies, individual components
of MetS are analyzed, to detect which component is more power-
fully related to Mets. As in the Framingham Study, the factor which
contributed most to cardiovascular disease outcome was high
blood pressure and low HDL [14]. In this study, multiple regression
analysis was done, taking angiographic ﬁnding as dependent vari-
able and waist circumference, FPG, S. TG, S. HDL, blood pressure as
independent variable. It reveals that three MetS components
(waist circumference above normal, hypertriglyceridemia, and
hypertension) signiﬁcantly predict the cardiovascular events in
the study population. Hypertriglyceridemia is also signiﬁcantly re-
lated to the severity of angiographic ﬁnds. But other parameters of
MetS were not related to the severity of different angiogram ﬁnd-
ings (single vessel/double vessel/triple vessel).
Here, the study of different clinical and biochemical character-
istics of angiogram positive subjects’ shows that they are mostly
of 40–60 years of age, mostly present or previous smokers and
62% had metabolic syndrome. In considering the individual param-
eter of MetS, hypertriglyceridemia and fasting dysglycemia were
present in ninety percent of angiogram positive subjects. Serum
cholesterol and LDL had the same type of distribution. In correlat-
ing the waist circumference with metabolic syndrome 62% had a
waist circumference above normal. Single vessel disease was the
most prevalent among the entire angiogram positive group. Among
the subjects undergoing coronary angiogram, 66.9% were diabetic,
and the presence of diabetes was signiﬁcantly related to presence
of CAD (positive angiographic ﬁnding). Among all study subjects,
diabetic subjects were experienced a greater prevalence of meta-
bolic syndrome than non-diabetic ones.
The metabolic abnormalities of MetS and diabetes are associ-
ated with atherosclerosis including coronary artery calciﬁcation
[15] and there is also involvement of other peripheral vessels. In
a large cohort study, it was found that low ankle brachial index
is associated with an increased risk of cardiovascular events and
mortality [16]. In this study, 25.3% of subjects undergoing CAG
had peripheral vascular disease. As the measurement of ankle bra-
chial index was undertaken manually by sphygmomanometer, it
may be that peripheral vascular disease may be more accurately
measured if a Doppler study is feasible, and in this situation,
peripheral vascular disease may be more prevalent among study
subjects. There may be other reasons for this controversy, as ABI
may be falsely raised in diabetic patients who have severe disease
in smaller arteries [17]. A good number of study subjects (66.9%)
were diabetic. Another noteworthy point is that ABI may appear
normal at rest in patients with signiﬁcant arterial disease [17].
Hence, post exercise vascular assessment can diagnose peripheral
vascular disease more accurately, which was not feasible for all
the study subjects undergoing coronary angiogram. For the diagno-
sis of a small number of cases of PVD in this study, the association
between peripheral vascular disease and coronary artery disease
was not signiﬁcant.
5. Study limitation
Sample size was not that much adequate because the special-
ized services provided by the cardiac center is only the part ofthe tertiary care hospital, BIRDEM. Color Doppler was not available
in that center. Further study including more number of subjects
may be helpful.
6. Conclusion
In this study different parameters of metabolic syndrome
among people undergoing coronary angiogram were studied.
Among them, waist circumference, hypertriglyceridemia and
hypertension I inﬂuenced cardiovascular disease occurrence.
Among the demographic parameters aging, male sex, smoking ha-
bit and family history of cardiovascular disease are related to
angiographic positivity. In this study, the presence of PVD does
not inﬂuence CAG positivity.
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